Clinical Reflections®Nonmelanoma Skin Cancers: Real-World Perspectives on Individualizing Care—Case Challenges in NMSC Management

Program Overview

In this activity, experts in the treatment of advanced nonmelanoma skin cancers (NMSC) will review 2 case challenges—one in CSCC and the other in BCC—that highlight the latest data and offer learners a unique opportunity to rethink key clinical decisions for optimal patient outcomes.

Credit Expired

Target Audience

This educational activity is designed to meet the needs of medical oncology physicians, dermatology physicians, and other clinicians involved in the management of cutaneous squamous cell carcinoma (CSCC) and basal cell carcinoma (BCC).

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Assess safety and efficacy data for checkpoint inhibitors in advanced cutaneous squamous cell carcinoma (CSCC)
  • Evaluate current and emerging options for systemic treatment in advanced basal cell carcinoma (BCC)

Activity Faculty

Migden_Photo 11_15_19

Michael R. Migden, MD

Professor, Department of Dermatology, Division of Internal Medicine
University of Texas MD Anderson Cancer Center
Houston, TX

Ahmad TarhiniDO NOT EDIT

Ahmad Tarhini, MD, PhD

Senior Member, Cutaneous Oncology and Immunology
Director, Cutaneous Clinical and Translational Research
H. Lee Moffitt Cancer Center and Research Institute
Professor, Oncologic Sciences
University of South Florida Morsani College of Medicine
Tampa, FL


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources